Published: 11. Februar 2026 Landmark ruling from the UK Supreme Court for software-related inventions A ruling issued by the UK’s Supreme Court on 11 February signals a change in the way many...
Published: 11. Februar 2026 Changes to the EPO’s PACE programme from 1 February 2026 The European Patent Office (EPO) has announced that as of 1 February 2026, it will no longer be...
Published: 8. Januar 2026 Changes to fees at the EPO from 1 April 2026 The European Patent Office (EPO) has announced that many of its fees will be increasing from 1 April...
Published: 21. November 2025 The Rapid Growth of Digital Agriculture Patents In September, the EPO published a press release highlighting the fast growth of the digital agriculture sector. In...
Published: 4. Juli 2025 European Patent Office clarifies what represents prior art in Enlarged Board of Appeal decision G1/23 A decision by the Enlarged Board of Appeal of the European Patent Office (EPO) has broadened the scope...
Published: 18. Juni 2025 EPO clarifies claim interpretation in Enlarged Board of Appeal decision G1/24 The EPO Enlarged Board of Appeal has announced that, while the claims are the basis for assessing the...
Published: 15. April 2025 Overview of updates to the Guidelines for examination Updates to the EPO (European Patent Office) Guidelines officially came into force on 1 April 2025. This article...
Published: 18. März 2025 At what point in appeal proceedings can the admissibility of an appeal be questioned? A recent decision (T0458/22) by an EPO Board of Appeal provides fresh guidance as to when arguments directed...
Published: 7. Februar 2025 No EPO Fee Increases in 2025 Traditionally, the European Patent Office (EPO) has reviewed its official fees every two years to account for inflation,...
Published: 5. Februar 2025 G2/24 – Can intervening infringers gain “appellant” status? The Enlarged Board of Appeal will decide upon the status granted to intervening infringers in Appeal proceedings, which...
Published: 29. Oktober 2024 T56/21 – No legal basis for description adaptation at the EPO The EPO’s insistence that the description be amended to conform to the claims (“description adaptation”) before a European...
Published: 17. Oktober 2024 When is a second medical use claim not a second medical use claim? A recent decision by an EPO Board of Appeal provides guidance on drafting claims to the therapeutic use...
